Overview

Role of Andi-d in Dengue Fever: a Pilot Study

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is evaluate the role of anti-d in dengue fever.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research
Treatments:
gamma-Globulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
Criteria
inclusion criteria:

- fever and thrombocytopenia with/without bleeding manifestations

- dengue serology positive patients

- platelet count ≤ 20,000/mm3

- Rh positive patients

- willing to give written informed consent

exclusion criteria:

- dengue serology positive but platelet count > 20,000/mm3

- Rh negative patients

- pregnant females